Gemma Llauradó1, Ksenia Sevastianova, Sanja Sädevirta, Antti Hakkarainen, Nina Lundbom, Marju Orho-Melander, Per-Henrik Groop, Carol Forsblom, Hannele Yki-Järvinen. 1. Minerva Foundation Institute for Medical Research (G.L., K.S., H.Y.-J.), FI-00290 Helsinki, Finland; Department of Medicine (K.S., S.S., H.Y.-J.), University of Helsinki, and Helsinki University Central Hospital, FI-00290 Helsinki, Finland; Helsinki Medical Imaging Center (A.H., N.L.), Helsinki University Central Hospital, FI-00290 Helsinki, Finland; Department of Clinical Sciences (M.O.-M.), Diabetes and Endocrinology, University Hospital Malmö, Lund University, SE-205 02 Malmö, Sweden; Folkhälsan Research Centre (P.-H.G., C.F.), Folkhälsan Institute of Genetics, Biomedicum Helsinki, FI-00290 Helsinki, Finland; and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (G.L.), Endocrinology Unit, Joan XXIII University Hospital, IISPV Pere Virgili Health Research Institute, Rovira i Virgili University, 43005 Tarragona, Spain.
Abstract
OBJECTIVES: Patients with type 1 diabetes mellitus (T1DM) lack the portal/peripheral insulin gradient, which might diminish insulin stimulation of hepatic lipogenesis and protect against development of nonalcoholic fatty liver disease (NAFLD). We compared liver fat content and insulin sensitivity of hepatic glucose production and lipolysis between overweight T1DM patients and nondiabetic subjects. MATERIALS AND METHODS: We compared 32 overweight adult T1DM patients and 32 nondiabetic subjects matched for age, body mass index (BMI), and gender. Liver fat content was measured using proton magnetic resonance spectroscopy ((1)H-MRS), body composition by magnetic resonance imaging, and insulin sensitivity using the euglycemic-hyperinsulinemic clamp technique (insulin 0.4 mU/kg · min combined with infusion of D-[3-(3)H]glucose). We also hypothesized that low liver fat might protect from obesity-associated increases in insulin requirements and, therefore, determined insulin requirements across BMI categories in 3164 T1DM patients. RESULTS: Liver fat content was significantly lower in T1DM patients than in nondiabetic subjects (0.6% [25th-75th quartiles, 0.3%-1.1%] vs 9.0% [3.0%-18.0%]; P < .001). The endogenous rate of glucose production (R(a)) during euglycemic hyperinsulinemia was significantly lower (0.4 [-0.7 to 0.8] mg/kg fat-free mass · min vs 0.9 [0.2-1.6] fat-free mass · min; P = .012) and the percent suppression of endogenous Ra by insulin was significantly greater (89% [78%-112%] vs 77% [50%-94%]; p = .009) in T1DM patients than in nondiabetic subjects. Serum nonesterified fatty acid concentrations during euglycemic hyperinsulinemia were significantly lower (78.5 [33.0-155.0] vs 306 [200.0-438.0] μmol/L; P < .001) and the percent suppression of nonesterified fatty acids significantly higher (89.1% [78.6%-93.3%] vs 51.4% [36.5%-71.1%]; P < .001) in T1DM patients than in nondiabetic subjects. Insulin doses were similar across BMI categories. CONCLUSIONS: T1DM patients might be protected from steatosis and hepatic insulin resistance. Obesity may not increase insulin requirements in T1DM.
OBJECTIVES:Patients with type 1 diabetes mellitus (T1DM) lack the portal/peripheral insulin gradient, which might diminish insulin stimulation of hepatic lipogenesis and protect against development of nonalcoholic fatty liver disease (NAFLD). We compared liver fat content and insulin sensitivity of hepatic glucose production and lipolysis between overweight T1DM patients and nondiabetic subjects. MATERIALS AND METHODS: We compared 32 overweight adult T1DM patients and 32 nondiabetic subjects matched for age, body mass index (BMI), and gender. Liver fat content was measured using proton magnetic resonance spectroscopy ((1)H-MRS), body composition by magnetic resonance imaging, and insulin sensitivity using the euglycemic-hyperinsulinemic clamp technique (insulin 0.4 mU/kg · min combined with infusion of D-[3-(3)H]glucose). We also hypothesized that low liver fat might protect from obesity-associated increases in insulin requirements and, therefore, determined insulin requirements across BMI categories in 3164 T1DM patients. RESULTS: Liver fat content was significantly lower in T1DM patients than in nondiabetic subjects (0.6% [25th-75th quartiles, 0.3%-1.1%] vs 9.0% [3.0%-18.0%]; P < .001). The endogenous rate of glucose production (R(a)) during euglycemic hyperinsulinemia was significantly lower (0.4 [-0.7 to 0.8] mg/kg fat-free mass · min vs 0.9 [0.2-1.6] fat-free mass · min; P = .012) and the percent suppression of endogenous Ra by insulin was significantly greater (89% [78%-112%] vs 77% [50%-94%]; p = .009) in T1DM patients than in nondiabetic subjects. Serum nonesterified fatty acid concentrations during euglycemic hyperinsulinemia were significantly lower (78.5 [33.0-155.0] vs 306 [200.0-438.0] μmol/L; P < .001) and the percent suppression of nonesterified fatty acids significantly higher (89.1% [78.6%-93.3%] vs 51.4% [36.5%-71.1%]; P < .001) in T1DM patients than in nondiabetic subjects. Insulin doses were similar across BMI categories. CONCLUSIONS: T1DM patients might be protected from steatosis and hepatic insulin resistance. Obesity may not increase insulin requirements in T1DM.
Authors: Jonathan M Hazlehurst; Conor Woods; Thomas Marjot; Jeremy F Cobbold; Jeremy W Tomlinson Journal: Metabolism Date: 2016-01-11 Impact factor: 8.694
Authors: Simon E Regnell; Martin J Hessner; Shuang Jia; Lina Åkesson; Hans Stenlund; Thomas Moritz; Daria La Torre; Åke Lernmark Journal: PLoS One Date: 2017-02-13 Impact factor: 3.240
Authors: Peter Wolf; Paul Fellinger; Lorenz Pfleger; Sabina Smajis; Hannes Beiglböck; Martin Gajdošík; Christian-Heinz Anderwald; Siegfried Trattnig; Anton Luger; Yvonne Winhofer; Martin Krššák; Michael Krebs Journal: Sci Rep Date: 2019-02-22 Impact factor: 4.379
Authors: Elina M Petäjä; You Zhou; Marika Havana; Antti Hakkarainen; Nina Lundbom; Jarkko Ihalainen; Hannele Yki-Järvinen Journal: Sci Rep Date: 2016-04-19 Impact factor: 4.379